Zhende Medical Co Ltd (603301) — Strategic Asset Allocation Index
Zhende Medical Co Ltd (603301) has a Strategic Asset Allocation Index of 45.6% as of June 2023. Strategic assets (PP&E of CN¥2.67 Billion plus long-term investments of CN¥-) total CN¥2.67 Billion, measured against net assets of CN¥5.85 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 603301 equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Zhende Medical Co Ltd Strategic Asset Allocation Index (2015–2021)
This chart shows how Zhende Medical Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2015 to 2021. As of June 2023, the index stands at 45.6%, representing strategic assets of CN¥2.67 Billion against net assets of CN¥5.85 Billion CNY. For live market cap and overall valuation, see Zhende Medical Co Ltd (603301) total market value.
Annual Strategic Asset Allocation Index for Zhende Medical Co Ltd (2015–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Zhende Medical Co Ltd from 2015 to 2021, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 603301 book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 49.0% | CN¥2.18 Billion | CN¥2.18 Billion | CN¥- | CN¥4.44 Billion | ▲ +14.7 pp |
| 2020 | 34.4% | CN¥1.54 Billion | CN¥1.54 Billion | CN¥- | CN¥4.47 Billion | ▼ -19.7 pp |
| 2019 | 54.1% | CN¥756.79 Million | CN¥756.79 Million | CN¥- | CN¥1.40 Billion | ▼ -1.9 pp |
| 2018 | 56.0% | CN¥630.02 Million | CN¥630.02 Million | CN¥- | CN¥1.12 Billion | ▼ -50.0 pp |
| 2017 | 106.1% | CN¥594.10 Million | CN¥594.10 Million | CN¥- | CN¥560.19 Million | ▼ -10.0 pp |
| 2016 | 116.0% | CN¥508.30 Million | CN¥508.30 Million | CN¥- | CN¥438.18 Million | ▼ -40.7 pp |
| 2015 | 156.7% | CN¥411.24 Million | CN¥411.24 Million | CN¥- | CN¥262.45 Million | — |